Pierre Jacquet
CIK: 0001783451
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mereo BioPharma Group plc
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 26, 2026MREO
Mereo BioPharma Group plc
Award(A)DirectShare Options (Right to buy)
66K shares- - Feb 26, 2026MREO
Mereo BioPharma Group plc
Award(A)DirectDeferred Restricted Stock Units
106.8K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
Award(A)DirectShare Options (Right to buy)
55K shares- - Feb 5, 2025MREO
Mereo BioPharma Group plc
Award(A)DirectDeferred Restricted Stock Units
15.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | Award(A) Share Options (Right to buy) | 66,000 | - | - | Direct |
| Feb 26, 2026 | MREO Mereo BioPharma Group plc | Award(A) Deferred Restricted Stock Units | 106,848 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award(A) Share Options (Right to buy) | 55,000 | - | - | Direct |
| Feb 5, 2025 | MREO Mereo BioPharma Group plc | Award(A) Deferred Restricted Stock Units | 15,243 | - | - | Direct |
1-4 of 4 transactions
About Jacquet Pierre
Jacquet Pierre (SEC CIK 0001783451) files insider reports with the SEC as Director of Mereo BioPharma Group plc (MREO).
Signal8 holds 2 ownership filings by Jacquet Pierre, all Form 4s, filed between Feb 6, 2025 and Feb 27, 2026. Those filings report 4 transactions, from Feb 5, 2025 to Feb 26, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jacquet Pierre's filings is in LONDON, X0.
Recent filings by Jacquet Pierre
Other insiders filing for Mereo BioPharma Group plc (MREO)
- Yoskowitz Marc J, Director
- Shames Daniel, Director
- Ekblom Anders, Director
- Bender Jeremy, Director
- PAKIANATHAN DEEPIKA, Director
- Jenkins Annalisa, Director